Loading…
Reported covered position: U.S. Amb. to Israel 2017-2021
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. via MR. DAVID FRIEDMAN
2026 · third_quarter · Q3
Issues related to the Export Administration Regulations and the entity list.
Filing targets: Commerce, Dept of (DOC)
OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. via MR. DAVID FRIEDMAN
2026 · second_quarter · Q2
Source: Senate LDA
Issues related to the Export Administration Regulations and the entity list.
Filing targets: Commerce, Dept of (DOC)
OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. via MR. DAVID FRIEDMAN
2026 · first_quarter · Q1
Issues related to the Export Administration Regulations and the entity list.
Filing targets: Commerce, Dept of (DOC)
TEVA PHARMACEUTICALS USA, INC. via MR. DAVID FRIEDMAN
2026 · first_quarter · Q1
Issues related to strengthening the domestic supply and manufacture of essential medicines.
Issues related to strengthening the domestic supply and manufacture of essential medicines.
Filing targets: Commerce, Dept of (DOC)
OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. via MR. DAVID FRIEDMAN
2026 · first_quarter · RA
Issues related to strategic advisory on cybersecurity policy matters.
Issues related to strategic advisory on cybersecurity policy matters.
OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. via MR. DAVID FRIEDMAN
2026 · first_quarter · RR
Issues related to strategic advisory on cybersecurity policy matters.
Issues related to strategic advisory on cybersecurity policy matters.
TEVA PHARMACEUTICALS USA, INC. via MR. DAVID FRIEDMAN
2025 · fourth_quarter · Q4
Issues related to strengthening the domestic supply and manufacture of essential medicines.
Issues related to strengthening the domestic supply and manufacture of essential medicines.
Filing targets: Commerce, Dept of (DOC)
TEVA PHARMACEUTICALS USA, INC. via MR. DAVID FRIEDMAN
2025 · fourth_quarter · RR
Issues related to strengthening the domestic supply and manufacture of essential medicines.
Issues related to strengthening the domestic supply and manufacture of essential medicines.